JNJ

166.87

-0.51%↓

NVS

116.6

-0.32%↓

ABT

128.27

+0.49%↑

TMO

474.8

-1.64%↓

ISRG

498.66

+0.44%↑

JNJ

166.87

-0.51%↓

NVS

116.6

-0.32%↓

ABT

128.27

+0.49%↑

TMO

474.8

-1.64%↓

ISRG

498.66

+0.44%↑

JNJ

166.87

-0.51%↓

NVS

116.6

-0.32%↓

ABT

128.27

+0.49%↑

TMO

474.8

-1.64%↓

ISRG

498.66

+0.44%↑

JNJ

166.87

-0.51%↓

NVS

116.6

-0.32%↓

ABT

128.27

+0.49%↑

TMO

474.8

-1.64%↓

ISRG

498.66

+0.44%↑

JNJ

166.87

-0.51%↓

NVS

116.6

-0.32%↓

ABT

128.27

+0.49%↑

TMO

474.8

-1.64%↓

ISRG

498.66

+0.44%↑

Search

VolitionRX Ltd

Closed

0.69 -1.43

Overview

Share price change

24h

Current

Min

0.68

Max

0.7

Key metrics

By Trading Economics

Income

381K

-5.5M

Sales

55K

246K

EPS

-0.06

Profit margin

-2,222.792

Employees

82

EBITDA

369K

-5.1M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+287.32% upside

Dividends

By Dow Jones

Next Earnings

13 Aug 2025

Market Stats

By TradingEconomics

Market Cap

26M

76M

Previous open

2.12

Previous close

0.69

VolitionRX Ltd Chart

Past performance is not a reliable indicator of future results.

Related News

29 Jul 2025, 23:57 UTC

Acquisitions, Mergers, Takeovers

EQT: To Spend Y407.82B for Tender Offer

29 Jul 2025, 23:56 UTC

Acquisitions, Mergers, Takeovers

EQT: Tender Offer Price Is Y5,700 a Share

29 Jul 2025, 23:54 UTC

Acquisitions, Mergers, Takeovers

EQT To Start Tender Offer for Fujitec

29 Jul 2025, 23:50 UTC

Market Talk

Nikkei May Fall Amid Uncertainty Over Earnings, Domestic Politics -- Market Talk

29 Jul 2025, 23:36 UTC

Market Talk

Gold Steady Ahead of FOMC Decision -- Market Talk

29 Jul 2025, 22:57 UTC

Market Talk

Perseus May Step Up Capital Management at FY 2025 Result -- Market Talk

29 Jul 2025, 22:50 UTC

Market Talk

Mondelez Warns of Price Increases in North America -- Market Talk

29 Jul 2025, 22:44 UTC

Acquisitions, Mergers, Takeovers

St Barbara: Potential Divestment of Nova Scotia Ops to be Weighed in 1Q FY26

29 Jul 2025, 22:41 UTC

Acquisitions, Mergers, Takeovers

St Barbara FY25 All-in Sustaining Cost A$4,582/Oz

29 Jul 2025, 22:41 UTC

Acquisitions, Mergers, Takeovers

St Barbara 4Q All-in Sustaining Cost A$4,613/Oz

29 Jul 2025, 22:35 UTC

Earnings

IGO Maintains Nova Life of Mine Production Guidance

29 Jul 2025, 22:35 UTC

Earnings

IGO Expects FY 2026 Greenbushes Output of 1.50 Million-1.65 Million Tons

29 Jul 2025, 22:35 UTC

Earnings

IGO Expects FY 2026 Greenbushes Cash Costs of A$310-A$360/Ton

29 Jul 2025, 22:34 UTC

Earnings

IGO Expects Train 1 of Kwinana Refinery to Be Fully Impaired

29 Jul 2025, 22:34 UTC

Earnings

IGO Expects to Impair Kwinana Refinery Assets by A$70 Million-A$90 Million

29 Jul 2025, 22:34 UTC

Market Talk
Earnings

Mondelez Snack Demand Holding Up Better in Europe Than U.S. -- Market Talk

29 Jul 2025, 22:33 UTC

Earnings

IGO Had A$279.7 Million of Cash at End-June

29 Jul 2025, 22:33 UTC

Earnings

IGO 4Q Underlying Free Cash A$2.4 Million

29 Jul 2025, 22:33 UTC

Earnings

IGO FY Sales Revenue A$512.5 Million

29 Jul 2025, 22:33 UTC

Earnings

IGO 4Q Sales Revenue A$126.9 Million, Up 15% on 3Q

29 Jul 2025, 22:32 UTC

Earnings

IGO FY Nickel Production 17,173 Tons

29 Jul 2025, 22:32 UTC

Earnings

IGO 4Q Nickel Production 5,107 Tons, Up 22% on 3Q

29 Jul 2025, 22:32 UTC

Earnings

IGO 4Q Lithium Hydroxide Production 2,126 Tons, Up 36% on 3Q

29 Jul 2025, 22:31 UTC

Market Talk
Earnings

Global Equities Roundup: Market Talk

29 Jul 2025, 22:31 UTC

Market Talk
Earnings

Mondelez Sees Consumers Trading Down, Buying in Bulk -- Market Talk

29 Jul 2025, 22:31 UTC

Earnings

IGO 4Q Spodumene Cash Cost A$366/Ton, Up 7% on 3Q

29 Jul 2025, 22:31 UTC

Earnings

IGO FY Spodumene Production 1.48 Million Tons

29 Jul 2025, 22:30 UTC

Earnings

IGO 4Q Spodumene Production 340,000 Tons, Flat on 3Q

29 Jul 2025, 22:30 UTC

Earnings

IGO 4Q Underlying Ebitda A$62 Million

29 Jul 2025, 22:22 UTC

Earnings

Starbucks Abandons Mobile Order, Pickup-Only Stores -- WSJ

Peer Comparison

Price change

VolitionRX Ltd Forecast

Price Target

By TipRanks

287.32% upside

12 Months Forecast

Average 2.75 USD  287.32%

High 3 USD

Low 2.5 USD

Based on 3 Wall Street analysts offering 12 month price targets forVolitionRX Ltd - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

3 ratings

2

Buy

1

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About VolitionRX Ltd

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.